Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale President and CEO sold 18,756 shares at an average $17.50 ($328,260)
  2. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $15.00 ($37,500)
  3. 4 Open-market sale President and CEO sold 4,781 shares at $15.00 ($71,715)
  4. 4 Other disposition 10% owner disposed of 850,000 shares (other)
  5. 4 Open-market sale President and CEO sold 4,781 shares at $15.52 ($74,201)
  6. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $15.47 ($38,675)
  7. 4 Open-market sale 10% owner sold 15,000 shares at $16.00 ($240,000)
  8. 4 Open-market sale Director sold 5,000 shares at $14.61 ($73,050)
  9. 4 Open-market sale President and CEO sold 4,481 shares at $15.00 ($67,215)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale President and CEO sold 300 shares at $15.00 ($4,500)
  17. 4 Grant or award President and CEO acquired 2,266 shares (grant or award)
  18. 4 Grant or award Chief Financial Officer acquired 2,698 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Exercise or conversion Chief Financial Officer acquired 19,967 shares (option exercise)

Page 15 of 20 · 400 filings